Search results for "Anticoagulants"
LMWH may offer best risk-benefit profile for thromboprophylaxis in medical inpatients
A meta-analysis found that an intermediate dose of low-molecular-weight heparin (LMWH) had the most favorable balance of risk and harms during hospitalization for acute illness, while unfractionated heparin and direct oral anticoagulants had the least.
https://acphospitalist.acponline.org/archives/2022/07/13/lmwh-may-offer-best-risk-benefit-profile-for-thromboprophylaxis-in-medical-inpatients.htm
13 Jul 2022
Adding contraception to the conversation
A hospitalist explains a recent call for her peers to consider their patients' family planning needs.
https://acphospitalist.acponline.org/archives/2022/07/06/free/adding-contraception-to-the-conversation.htm
6 Jul 2022
Hypocoagulopathy
Correct coding and sequencing of codes for patients admitted with hypocoagulopathy can be tricky.
https://acphospitalist.acponline.org/archives/2022/05/18/coding-corner-hypocoagulopathy.htm
18 May 2022
Manage meds to treat GI bleeding before, after endoscopy
Care of inpatients with GI bleeding is complicated and multidisciplinary, but hospitalists can contribute by starting and stopping the right drugs, according to a speaker at Internal Medicine Meeting 2022.
https://acphospitalist.acponline.org/archives/2022/05/18/free/manage-meds-to-treat-gi-bleeding-before-after-endoscopy.htm
18 May 2022
When your patient is on dialysis
A nephrologist ran down the initial steps hospitalists should take after admitting a long-term dialysis patient during a lecture at Internal Medicine Meeting 2022.
https://acphospitalist.acponline.org/archives/2022/05/11/when-your-patient-is-on-dialysis.htm
11 May 2022
Continuing aspirin for no reason?
A speaker made the case for anticoagulant monotherapy in selected patients with stable coronary artery disease and atrial fibrillation during a “Things We Do For No Reason” session at SHM Converge 2022.
https://acphospitalist.acponline.org/archives/2022/04/27/continuing-aspirin-for-no-reason.htm
27 Apr 2022
Risk for DVT, PE, bleeding after COVID-19, but low long-term VTE recurrence risk
One study found increased risk for deep venous thrombosis (DVT) for up to three months after COVID-19, pulmonary embolism (PE) for up to six months, and bleeding for up to two months, while another showed low rates of venous thromboembolism (VTE) recurrence in the year after infection.
https://acphospitalist.acponline.org/archives/2022/04/13/free/risk-for-dvt-pe-bleeding-seen-after-covid-19-long-term-risk-for-vte-recurrence-may-be-low.htm
13 Apr 2022
Negative trials of prone positioning, antiplatelet therapy for COVID-19
Telling inpatients to lay on their stomachs did not significantly improve outcomes, one study found, while others offered some mixed results on the effects of aspirin and P2Y12 inhibitors. Additional research showed that a commonly used triage score doesn't work for COVID-19 and that hospitalists' worry about catching the virus impaired their well-being.
https://acphospitalist.acponline.org/archives/2022/03/30/free/negative-trials-of-prone-positioning-antiplatelet-therapy-for-covid-19.htm
30 Mar 2022
DOACs better than heparin for periop thromboprophylaxis, review finds
The systematic review and network meta-analysis found lower rates of symptomatic venous thromboembolism in surgical patients given direct oral anticoagulants (DOACs) versus the standard dose of low-molecular-weight heparin, without a significant increase in bleeding.
https://acphospitalist.acponline.org/archives/2022/03/16/doacs-better-than-heparin-for-periop-thromboprophylaxis.htm
16 Mar 2022
Pulmonary embolism
For optimal documentation, coding, and reimbursement, the location or type of pulmonary embolism needs to be clearly identified.
https://acphospitalist.acponline.org/archives/2022/02/23/coding-corner-pulmonary-embolism.htm
23 Feb 2022